Caroline Humer; Additional reporting by Rod Nickel in Winnipeg, Manitoba; Editing by Bernadette Baum and Lisa Von Ahn

Articles by Caroline Humer; Additional reporting by Rod Nickel in Winnipeg, Manitoba; Editing by Bernadette Baum and Lisa Von Ahn

Allergan agrees to $66 billion Actavis deal; Valeant walks

Allergan Inc (AGN.N) on Monday accepted a $66 billion takeover bid from Actavis Plc (ACT.N), closing the door on a hostile offer from activist investor William Ackman and Valeant Pharmaceuticals International Inc (VRX.TO).

Nov 17, 2014 11:59 AM EST

Allergan agrees to $66 billion Actavis deal; Valeant walks

IRS To Send Out Special 'Stimulus' Payments To 1 Million Taxpayers

'It's Vaporware': Crypto Users Troll Tether's $775M Bet On Rumble

Altcoins $HBAR, $SUI, $XRP Lead Crypto Market Gains Ahead Of Christmas Eve

Salmonella Scare: FDA Elevates Costco Egg Recall To High Risk – Are Your Eggs Safe?

Biden Scraps Two Student Loan Forgiveness Plans: What Borrowers Must Know

Hyperliquid Sees Massive Outflows Amid Concerns Over Alleged Presence Of North Korea-Linked Hackers

Expert Mobile Gamer? Earn Real Money In 2025 With Your Gaming Skills Through These Apps

Biden Scraps Two Student Loan Forgiveness Plans: What Borrowers Must Know

Salmonella Scare: FDA Elevates Costco Egg Recall To High Risk – Are Your Eggs Safe?

Altcoins $HBAR, $SUI, $XRP Lead Crypto Market Gains Ahead Of Christmas Eve

IRS To Send Out Special 'Stimulus' Payments To 1 Million Taxpayers